Raia Drogasil S.A.

Total Valuation

Raia Drogasil S.A. carries a market capitalization of 6.73B, placing it among publicly traded companies globally. Its enterprise value stands at 39.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Raia Drogasil S.A. currently has 1.75B shares outstanding.

Valuation Ratios

Raia Drogasil S.A. trades at a trailing price-to-earnings ratio of 33.40. The price-to-sales ratio is 0.88, and the price-to-book ratio stands at 4.29.

Enterprise Valuation

On an enterprise value basis, Raia Drogasil S.A. trades at an EV/EBITDA multiple of 19.06 and an EV/FCF ratio of 13.53. The EV/Sales ratio of 1.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.06 provides insight into valuation relative to core operating earnings.

Financial Position

Raia Drogasil S.A. maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 117.86, indicating elevated leverage, while an interest coverage ratio of 2.35 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Raia Drogasil S.A. posts a return on equity of 12.73 and a return on invested capital of 11.51.

Taxes

Over the trailing twelve months, Raia Drogasil S.A. has paid 106.24M in income taxes, reflecting an effective tax rate of 11.06.

Stock Price Statistics

Raia Drogasil S.A.'s stock has gained approximately 18.82716% over the past 52 weeks. The 50-day moving average sits at 3.63, while the 200-day moving average is 4.22.

Income Statement

Over the trailing twelve months, Raia Drogasil S.A. generated 33.73B in revenue and converted that into 888.41M in net income, yielding earnings per share of 0.51. EBITDA reached 2.06B, while operating income came in at 2.06B.

Balance Sheet

Raia Drogasil S.A. holds 652.95M in cash and equivalents against 8.59B in total debt, resulting in a net debt position of 2.92B. Total book value stands at 7.29B, with working capital of 4.12B providing operational flexibility.

Cash Flow

Raia Drogasil S.A. produced 1.11B in operating cash flow over the past twelve months. After subtracting -1.02B in capital expenditures, free cash flow totaled 90.27M - equivalent to 0.05 per share.

Margins

Raia Drogasil S.A. operates with a gross margin of 31.59, reflecting its pricing power and cost economics. The operating margin of 6.10 and net profit margin of 2.63 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Raia Drogasil S.A.'s most recent stock split took place on December 24, 2025 with a 50:51 split ratio.

Scores

Raia Drogasil S.A. posts an Altman Z-Score of 3.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.